Salman et al. established the role of CD4-CD28-4-1BB-CD3ζ CAR-NK-92 cells in robustly eliminating CD4 + AML cells ex vivo and in mouse xenografts [119]. This evidence concerns the gene CD4 and acute myeloid leukemia.